ClinConnect ClinConnect Logo
Search / Trial NCT00828425

Management of Diabetes Mellitus Patients With Retinopathy

Launched by ASTRAZENECA · Jan 23, 2009

Trial Information

Current as of June 20, 2025

Completed

Keywords

Diabetes Mellitus Retinopathy Management Of Diabetic Patients With Retinopathy

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diabetic patients
  • Diabetic retinopathy

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Dattwil, Ag, Switzerland

Hausen B. Brugg, Ag, Switzerland

Lenzburg, Ag, Switzerland

Lupfig, Ag, Switzerland

Muri Ag, Ag, Switzerland

Rheinfelden, Ag, Switzerland

Schinznach Dorf, Ag, Switzerland

Spreitenbach, Ag, Switzerland

Bern, Be, Switzerland

Moutier, Be, Switzerland

Unterseen, Be, Switzerland

Diegten, Bl, Switzerland

Laufen, Bl, Switzerland

Basel, Bs, Switzerland

Estavayer Le Lac, Fr, Switzerland

Fribourg, Fr, Switzerland

Collonge Bellerive, Ge, Switzerland

Geneve, Ge, Switzerland

Le Grand Saconnex, Ge, Switzerland

Les Acacias, Ge, Switzerland

Versoix, Ge, Switzerland

Chur, Gr, Switzerland

Ilanz, Gr, Switzerland

Samedan, Gr, Switzerland

Alle, Ju, Switzerland

Luzern, Lu, Switzerland

Rothenburg, Lu, Switzerland

Le Locle, Ne, Switzerland

Kerns, Ow, Switzerland

Oberuzwil, Sg, Switzerland

Rorschach, Sg, Switzerland

St. Gallen, Sg, Switzerland

Wangs, Sg, Switzerland

Schaffhausen, Sh, Switzerland

Kussnacht Am Rigi, Sz, Switzerland

Tuggen, Sz, Switzerland

Kreuzlingen, Tg, Switzerland

Ascona, Ti, Switzerland

Locarno, Ti, Switzerland

Lugano, Ti, Switzerland

Viganello, Ti, Switzerland

Aigle, Vd, Switzerland

Bassins, Vd, Switzerland

Bex, Vd, Switzerland

Chateau D'oex, Vd, Switzerland

Clarens, Vd, Switzerland

Eysins, Vd, Switzerland

Lausanne, Vd, Switzerland

Nyon, Vd, Switzerland

Prilly, Vd, Switzerland

Renens Vd, Vd, Switzerland

Salavaux, Vd, Switzerland

St Legier, Vd, Switzerland

Vevey, Vd, Switzerland

Ardon, Vs, Switzerland

Evionnaz, Vs, Switzerland

Saviese, Vs, Switzerland

Sierre, Vs, Switzerland

Sion, Vs, Switzerland

Bassersdorf, Zh, Switzerland

Egg B. Zurich, Zh, Switzerland

Winterthur, Zh, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials